Clinical Trial Detail

NCT ID NCT03330990
Title Evaluate the Effect of Entrectinib on the Pharmacokinetics of Midazolam in Cancer Patients
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements no
Sponsors Ignyta, Inc.
Indications

Advanced Solid Tumor

Therapies

Entrectinib

Age Groups: adult senior

No variant requirements are available.